Related references
Note: Only part of the references are listed.Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by National Institutes of Health Monovalent Dengue Virus Vaccines
Jesica A. Swanstrom et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies
Rajendra Raut et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Antigenic Characterization of a Novel Recombinant GII.P16-GII.4 Sydney Norovirus Strain With Minor Sequence Variation Leading to Antibody Escape
Lisa C. Lindesmith et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Analyzing the Human Serum Antibody Responses to a Live Attenuated Tetravalent Dengue Vaccine Candidate
Jesica A. Swanstrom et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes
Emily N. Gallichotte et al.
PLOS PATHOGENS (2018)
Reconstruction of antibody dynamics and infection histories to evaluate dengue risk
Henrik Salje et al.
NATURE (2018)
Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials
Michal Juraska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Genetic Variation between Dengue Virus Type 4 Strains Impacts Human Antibody Binding and Neutralization
Emily N. Gallichotte et al.
CELL REPORTS (2018)
Dissecting Antibodies Induced by a Chimeric Yellow Fever-Dengue, Live-Attenuated, Tetravalent Dengue Vaccine (CYD-TDV) in Naive and Dengue-Exposed Individuals
Sandra Henein et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination
Usha K. Nivarthi et al.
JOURNAL OF VIROLOGY (2017)
Antibody-dependent enhancement of severe dengue disease in humans
Leah C. Katzelnick et al.
SCIENCE (2017)
Immune correlates of protection for dengue: State of the art and research agenda
Leah C. Katzelnick et al.
VACCINE (2017)
Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes
Daniela V. Andrade et al.
MBIO (2017)
Dissecting the human serum antibody response to secondary dengue virus infections
Bhumi Patel et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Genetic epidemiology of dengue viruses in phae III trials of the CYD tetravalent dengue vaccine and implications for efficacy
Maia A. Rabaa et al.
ELIFE (2017)
Epitope Addition and Ablation via Manipulation of a Dengue Virus Serotype 1 Infectious Clone
Emily N. Gallichotte et al.
MSPHERE (2017)
Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4
Douglas G. Widman et al.
SCIENTIFIC REPORTS (2017)
Dengue Virus (DENV) Neutralizing Antibody Kinetics in Children After Symptomatic Primary and Postprimary DENV Infection
Hannah E. Clapham et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Homotypic Dengue Virus Reinfections in Nicaraguan Children
Jesse J. Waggoner et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Evidence-based risk assessment and communication: a new global dengue-risk map for travellers and clinicians
Emily S. Jentes et al.
JOURNAL OF TRAVEL MEDICINE (2016)
Functional Transplant of a Dengue Virus Serotype 3 (DENV3)-Specific Human Monoclonal Antibody Epitope into DENV1
William B. Messer et al.
JOURNAL OF VIROLOGY (2016)
Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort
Leah C. Katzelnick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Antigenic Variation of East/Central/South African and Asian Chikungunya Virus Genotypes in Neutralization by Immune Sera
Chong-Long Chua et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Incomplete Protection against Dengue Virus Type 2 Re-infection in Peru
Brett M. Forshey et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Highly divergent dengue virus type 1 genotype sets a new distance record
Alyssa T. Pyke et al.
SCIENTIFIC REPORTS (2016)
Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers
Guntur Fibriansah et al.
SCIENCE (2015)
Dengue viruses cluster antigenically but not as discrete serotypes
Leah C. Katzelnick et al.
SCIENCE (2015)
A New Quaternary Structure Epitope on Dengue Virus Serotype 2 Is the Target of Durable Type-Specific Neutralizing Antibodies
E. N. Gallichotte et al.
MBIO (2015)
A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins
Guntur Fibriansah et al.
NATURE COMMUNICATIONS (2015)
Preexisting Neutralizing Antibody Responses Distinguish Clinically Inapparent and Apparent Dengue Virus Infections in a Sri Lankan Pediatric Cohort
Kizzmekia S. Corbett et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus
Wanwisa Dejnirattisai et al.
NATURE IMMUNOLOGY (2015)
A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface
Guntur Fibriansah et al.
EMBO MOLECULAR MEDICINE (2014)
Dengue Virus Neutralizing Antibody Levels Associated with Protection from Infection in Thai Cluster Studies
Darunee Buddhari et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies
M. Santak et al.
EPIDEMIOLOGY AND INFECTION (2013)
The global distribution and burden of dengue
Samir Bhatt et al.
NATURE (2013)
Worldwide Spread of Dengue Virus Type 1
Christian Julian Villabona-Arenas et al.
PLOS ONE (2013)
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
Arunee Sabchareon et al.
LANCET (2012)
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions
Ruklanthi de Alwis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses
Dennis R. Burton et al.
SCIENCE (2012)
The Structural Basis for Serotype-Specific Neutralization of Dengue Virus by a Human Antibody
Ee Ping Teoh et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Development and Characterization of a Reverse Genetic System for Studying Dengue Virus Serotype 3 Strain Variation and Neutralization
William B. Messer et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Evaluation of the Traditional and Revised WHO Classifications of Dengue Disease Severity
Federico Narvaez et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
New Dengue Virus Type 1 Genotype in Colombo, Sri Lanka
Hasitha A. Tissera et al.
EMERGING INFECTIOUS DISEASES (2011)
The Nicaraguan Pediatric Dengue Cohort Study: Study Design, Methods, Use of Information Technology, and Extension to Other Infectious Diseases
Guillermina Kuan et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
Severe Dengue, Epidemics in Sri Lanka, 2003-2006
Nalaka Kanakaratne et al.
EMERGING INFECTIOUS DISEASES (2009)
Antibody to dengue 1 detected more than 6 years after infection
Allison Imrie et al.
VIRAL IMMUNOLOGY (2007)
Comparison of plaque- and flow cytometry-based methods for measuring dengue virus neutralization
Annette A. Kraus et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma
Pei Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Neutralizing antibodies after infection with dengue 1 virus
Maria G. Guzman et al.
EMERGING INFECTIOUS DISEASES (2007)
Flavivirus membrane fusion
Karin Stiasny et al.
JOURNAL OF GENERAL VIROLOGY (2006)
High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua
Angel Balmaseda et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2006)
Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein
Y Modis et al.
JOURNAL OF VIROLOGY (2005)
Structure of the dengue virus envelope protein after membrane fusion
Y Modis et al.
NATURE (2004)
Conformational changes of the flavivirus E glycoprotein
Y Zhang et al.
STRUCTURE (2004)
A ligand-binding pocket in the dengue virus envelope glycoprotein
Y Modis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Epidemiology of dengue in Sri Lanka before and after the emergence of epidemic dengue hemorrhagic fever
WB Messer et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2002)
Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion
RJ Kuhn et al.
CELL (2002)
Share Paper
